WebbSofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY):an open-label, single-arm, phase 4, multicentre trial - CORE Reader … Webb13 nov. 2024 · In our study, the median HCV RNA level was 175,455 IU/mL, with only five cases had HCV RNA below 3000 IU/mL. Considering the relatively high viral load among most patients, HCV Ag could potentially be used as another method to diagnose active HCV infection in HD population.
Strategies for the improvement of HCV testing and diagnosis
WebbBackground: This study investigated treatment adherence among people with recent injecting drug use in a study of sofosbuvir/velpatasvir therapy for HCV infection.. … WebbMethods: SIMPLIFY is an international open-label study that recruited participants with recent injecting drug use (previous six months) and chronic HCV genotype (G) 1-6 … mw2 timed out while checking permissions
HCV Test and Treat Utilizing Simplified HCV Patient Education
WebbBackground: This study investigated treatment adherence among people with recent injecting drug use in a study of sofosbuvir/velpatasvir therapy for HCV infection. … Webb7 maj 2024 · The goal of the SIMPLIFY study is to get information about whether or not it is safe to stop either inhaled hypertonic saline or Pulmozyme (dornase alfa) by testing if there is a change in lung function in subjects with cystic fibrosis (CF) who are assigned to stop their chronic medication (either hypertonic saline or Pulmozyme) as compared to those … WebbAdherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: the SIMPLIFY study. ... the SIMPLIFY study. Int J Drug Policy. 2024;62:14-23. Publication Type: Journal Article. Authors: Cunningham, Evan B; Amin, Janaki; Feld, Jordan J; et, al. Source: Int J Drug Policy, Volume 62, p.14-23 (2024 ... mw2 tier 1 health